SALUBRISBIO - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87425888
Serial Number
87425888
Registration Number
5748146
Word Mark
SALUBRISBIO
Status
700 - Registered
Status Date
2019-05-14
Filing Date
2017-04-26
Registration Number
5748146
Registration Date
2019-05-14
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form Typeset
Published for Opposition Date
2019-02-26
Attorney Name
Timothy T. Wang
Law Office Assigned Location Code
M40
Employee Name
KEELEY, ALISON REBECCA
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Description of Mark
The mark consists of stylized word of "SalubrisBio".
Goods and Services
Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biological preparations for medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes in the nature of medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Injections, namely, vaccines and injectable medicines, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of components of finished pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Dietetic substances adapted for medical use, namely, dietetic beverages and food for medical purposes, the foregoing dietetic food and beverages containing vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, and containing mineral food-supplements, the foregoing dietetic foods and beverages are used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2017-05-03
Primary Code
005
Current Trademark Owners
Party Name
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Name
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
TIMOTHY T. WANG
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
China P.Rep.False
China P.Rep.False
Trademark Events
Event DateEvent Description
2017-04-29NEW APPLICATION ENTERED IN TRAM
2017-05-03NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2017-07-24ASSIGNED TO EXAMINER
2017-07-27EXAMINERS AMENDMENT -WRITTEN
2017-07-27EXAMINERS AMENDMENT E-MAILED
2017-07-27NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2017-07-27EXAMINER'S AMENDMENT ENTERED
2017-07-27APPROVED FOR PUB - PRINCIPAL REGISTER
2017-08-30NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2017-09-19PUBLISHED FOR OPPOSITION
2017-09-19OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2017-11-14NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2018-06-18ABANDONMENT - NO USE STATEMENT FILED
2018-06-18ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
2018-07-17TEAS PETITION TO REVIVE RECEIVED
2018-07-17PETITION TO REVIVE-GRANTED
2018-07-17EXTENSION RECEIVED WITH TEAS PETITION
2018-07-18NOTICE OF REVIVAL - E-MAILED
2018-09-06CASE ASSIGNED TO INTENT TO USE PARALEGAL
2018-05-14EXTENSION 1 FILED
2018-09-21EXTENSION 1 GRANTED
2018-09-22NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2018-09-24TEAS PETITION TO AMEND BASIS RECEIVED
2018-10-05ASSIGNED TO PETITION STAFF
2018-10-09PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
2018-12-17ABANDONMENT - NO USE STATEMENT FILED
2018-12-17ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
2019-01-22CASE ASSIGNED TO INTENT TO USE PARALEGAL
2019-01-22REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
2018-11-14NOTICE OF ALLOWANCE CANCELLED
2019-01-231(B) BASIS DELETED; NEW BASIS REQUESTED
2019-01-25NOTICE OF REINSTATEMENT MAILED
2019-02-06NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-02-26PUBLISHED FOR OPPOSITION
2019-02-26OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2019-05-14REGISTERED-PRINCIPAL REGISTER